Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.15 EUR | +0.52% | +3.79% | +14.78% |
Apr. 25 | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
Apr. 25 | GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines | MT |
Sales 2024 * | 31.48B 39.29B 36.73B | Sales 2025 * | 33.38B 41.66B 38.95B | Capitalization | 67.54B 84.31B 78.82B |
---|---|---|---|---|---|
Net income 2024 * | 5.66B 7.07B 6.61B | Net income 2025 * | 6.4B 7.98B 7.47B | EV / Sales 2024 * | 2.53 x |
Net Debt 2024 * | 12.17B 15.19B 14.2B | Net Debt 2025 * | 8.93B 11.15B 10.42B | EV / Sales 2025 * | 2.29 x |
P/E ratio 2024 * |
11.9
x | P/E ratio 2025 * |
10.6
x | Employees | 70,212 |
Yield 2024 * |
3.68% | Yield 2025 * |
3.92% | Free-Float | 92.52% |
Latest transcript on GSK plc
1 day | +0.52% | ||
1 week | +3.79% | ||
Current month | -3.51% | ||
1 month | -2.06% | ||
3 months | +7.58% | ||
6 months | +16.06% | ||
Current year | +14.78% |
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 10-04-30 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
James Ford
CMP | Compliance Officer | - | 95-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
Jonathan Symonds
CHM | Chairman | 66 | 19-08-31 |
Urs Rohner
BRD | Director/Board Member | 65 | 14-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 19.15 | +0.52% | 400 |
24-04-25 | 19.05 | +1.87% | 3,643 |
24-04-24 | 18.7 | -1.66% | 647 |
24-04-23 | 19.02 | +1.01% | 278 |
24-04-22 | 18.82 | +2.03% | 116 |
Delayed Quote Deutsche Boerse AG, April 26, 2024 at 03:41 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- GSK Stock
- GS71 Stock